How Is Exon Skipping Therapy Redefining DMD Treatment
Exon skipping therapy for Duchenne muscular dystrophy — the antisense oligonucleotide (ASO) approach using synthetic nucleic acid molecules that bind pre-mRNA splicing signals to cause targeted exon exclusion during RNA processing, converting the out-of-frame DMD gene mutations causing Duchenne muscular dystrophy into in-frame mutations producing a shorter but partially functional...
0 Yorumlar 0 Paylaşımlar 30 Görüntülenme 0 İncelemeler
Sponsorlu

GET VERİFİED ACCOUNTS 2$ ONLY

Beyond data, AI prioritizes trust. Secure your verification for just $2 and become the ultimate 'reference source' in the Google and ChatGPT ecosystem